AngioDynamics (ANGO) delivered earnings and revenue surprises of 63.64% and 2.36%, respectively, for the quarter ended November 2024. Do the numbers hold clues to what lies ahead for the stock?

AngioDynamics Inc (NASDAQ:ANGO) is set to release its Q2 2025 earnings on Jan 8, 2025. The consensus estimate for Q2 2025 ...

AngioDynamics Inc. (ANGO) revealed Loss for second quarter that decreased from last year but beat the Street estimates. The ...

ABUJA – THE Northern Elders Forum, NEF, Wednesday, appointed a new Spokesperson, Prof Abubakar Jika Jiddere.

In a bold move to improve efficiency, Ango initiated the takeover of revenue collection for the FCT’s area councils by the FCT-IRS. This centralization effort is designed to minimize leakages and ...

AngioDynamics, Inc. (NASDAQ:ANGO – Get Free Report)’s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of $7.11 and traded as high ...

AngioDynamics, Inc. ANGO, yesterday, announced the receipt of the FDA’s 510(k) clearance for the NanoKnife System for prostate tissue ablation. The clearance for the NanoKnife System for ...

S&P 500 E-Mini futures (ESH25) are trending down -0.02% this morning as investors awaited the Federal Reserve’s December ...